What COVID-19 can mean for people with hemophilia beyond the infection risk

Hortensia De la Corte-Rodriguez1, M Teresa Alvarez-Roman2, E Carlos Rodriguez-Merchan3

  • 1Department of Physical Medicine and Rehabilitation, La Paz University Hospital-IdiPaz , Madrid, Spain.

Expert Review of Hematology
|September 1, 2020
PubMed

Insights

The COVID-19 pandemic poses unique challenges for hemophilia patients, impacting healthcare and lifestyle. This report explores potential long-term effects beyond infection risk and suggests mitigation strategies.

Area of Science:

  • Hematology
  • Public Health
  • Pandemic Response

Background:

  • The COVID-19 pandemic necessitated global social isolation measures.
  • These measures significantly alter healthcare access and lifestyle management for individuals with chronic conditions.
  • Hemophilia patients face compounded risks due to their specific health management needs.

Purpose of the Study:

  • To analyze the multifaceted implications of the COVID-19 pandemic for hemophilia patients.
  • To extend the understanding of pandemic effects beyond direct viral infection risks.
  • To propose strategies for mitigating adverse outcomes in this vulnerable population.

Main Methods:

  • This report synthesizes existing knowledge and expert opinion.
  • It reviews potential impacts across clinical, care, and lifestyle domains.
  • It identifies areas requiring proactive management and intervention.

Main Results:

  • Social isolation measures can disrupt essential hemophilia care routines.
  • Patients may experience increased physical, nutritional, and mental health challenges.
  • Long-term disability and pain management may be significantly affected.

Conclusions:

  • A collaborative approach involving patients, healthcare providers, and society is crucial.
  • Proactive strategies are needed to minimize the pandemic's detrimental effects on hemophilia patients.
  • Addressing clinical, psychosocial, and rehabilitative aspects is vital for patient well-being.
Abstract

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.7K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
696
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
177
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
625